LENSAR, Inc. (LNSR) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Orlando, FL, United States. The current CEO is Nicholas T. Curtis.
LNSR has IPO date of 2020-10-02, 140 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $73.06M.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
